+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Electronic Skin Patch Market Size, Share & Trends Analysis Report By End User, By Type, By Wireless Connectivity, By Application, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5978653
The Europe Electronic Skin Patch Market would witness market growth of 11.3% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Electronic Skin Patch Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of$1.86 billion by 2031. The UK market is exhibiting a CAGR of 10.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 12.1% during (2024 - 2031).



The applications of electronic skin patches are diverse and multifaceted, encompassing a wide range of fields, including healthcare, sports, research, and consumer wellness. For example, electronic skin patches are extensively used for real-time monitoring of vital signs such as heart rate, blood pressure, respiratory rate, and body temperature.

Additionally, they provide continuous data streams that enable healthcare professionals to remotely assess patients’ health status and detect early signs of deterioration or abnormality. This application is particularly valuable in hospital settings, home care, and remote patient monitoring programs.

The prevalence of chronic diseases in the UK is driving innovation in the electronic skin patch market. Companies are investing in research and development to enhance the capabilities of these devices, making them more accurate, comfortable, and user-friendly. Technological advancements such as improved sensors, wireless connectivity, and advanced data analytics are making electronic skin patches increasingly attractive for both patients and healthcare providers in the UK.

Based on End User, the market is segmented into Healthcare, Fitness & Sports and Others. Based on Type, the market is segmented into Monitoring & Diagnostic and Therapeutic. Based on Wireless Connectivity, the market is segmented into Connected and Non-connected. Based on Application, the market is segmented into Diabetes Management, Cardiovascular Monitoring, General Patient Monitoring, Electrical Simulation, Temperature Sensing, Iontophoresis, Wound Monitoring & Treatment, Sweat Sensing, Motion Sensing and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Abbott Laboratories
  • DexCom, Inc.
  • Medtronic PLC
  • Insulet Corporation
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • The Surgical Company
  • VivaLNK, Inc.
  • Blue Spark Technologies, Inc.
  • Senseonics Holdings, Inc.

Market Report Segmentation

By End User

  • Healthcare
  • Fitness & Sports
  • Others

By Type

  • Monitoring & Diagnostic
  • Therapeutic

By Wireless Connectivity

  • Connected
  • Non-connected

By Application

  • Diabetes Management
  • Cardiovascular Monitoring
  • General Patient Monitoring
  • Electrical Simulation
  • Temperature Sensing
  • Iontophoresis
  • Wound Monitoring & Treatment
  • Sweat Sensing
  • Motion Sensing
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Electronic Skin Patch Market, by End User
1.4.2 Europe Electronic Skin Patch Market, by Type
1.4.3 Europe Electronic Skin Patch Market, by Wireless Connectivity
1.4.4 Europe Electronic Skin Patch Market, by Application
1.4.5 Europe Electronic Skin Patch Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Electronic Skin Patch Market by End User
4.1 Europe Healthcare Market by Country
4.2 Europe Fitness & Sports Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Electronic Skin Patch Market by Type
5.1 Europe Monitoring & Diagnostic Market by Country
5.2 Europe Therapeutic Market by Country
Chapter 6. Europe Electronic Skin Patch Market by Wireless Connectivity
6.1 Europe Connected Market by Country
6.2 Europe Non-connected Market by Country
Chapter 7. Europe Electronic Skin Patch Market by Application
7.1 Europe Diabetes Management Market by Country
7.2 Europe Cardiovascular Monitoring Market by Country
7.3 Europe General Patient Monitoring Market by Country
7.4 Europe Electrical Simulation Market by Country
7.5 Europe Temperature Sensing Market by Country
7.6 Europe Iontophoresis Market by Country
7.7 Europe Wound Monitoring & Treatment Market by Country
7.8 Europe Sweat Sensing Market by Country
7.9 Europe Motion Sensing Market by Country
7.1 Europe Others Market by Country
Chapter 8. Europe Electronic Skin Patch Market by Country
8.1 Germany Electronic Skin Patch Market
8.1.1 Germany Electronic Skin Patch Market by End User
8.1.2 Germany Electronic Skin Patch Market by Type
8.1.3 Germany Electronic Skin Patch Market by Wireless Connectivity
8.1.4 Germany Electronic Skin Patch Market by Application
8.2 UK Electronic Skin Patch Market
8.2.1 UK Electronic Skin Patch Market by End User
8.2.2 UK Electronic Skin Patch Market by Type
8.2.3 UK Electronic Skin Patch Market by Wireless Connectivity
8.2.4 UK Electronic Skin Patch Market by Application
8.3 France Electronic Skin Patch Market
8.3.1 France Electronic Skin Patch Market by End User
8.3.2 France Electronic Skin Patch Market by Type
8.3.3 France Electronic Skin Patch Market by Wireless Connectivity
8.3.4 France Electronic Skin Patch Market by Application
8.4 Russia Electronic Skin Patch Market
8.4.1 Russia Electronic Skin Patch Market by End User
8.4.2 Russia Electronic Skin Patch Market by Type
8.4.3 Russia Electronic Skin Patch Market by Wireless Connectivity
8.4.4 Russia Electronic Skin Patch Market by Application
8.5 Spain Electronic Skin Patch Market
8.5.1 Spain Electronic Skin Patch Market by End User
8.5.2 Spain Electronic Skin Patch Market by Type
8.5.3 Spain Electronic Skin Patch Market by Wireless Connectivity
8.5.4 Spain Electronic Skin Patch Market by Application
8.6 Italy Electronic Skin Patch Market
8.6.1 Italy Electronic Skin Patch Market by End User
8.6.2 Italy Electronic Skin Patch Market by Type
8.6.3 Italy Electronic Skin Patch Market by Wireless Connectivity
8.6.4 Italy Electronic Skin Patch Market by Application
8.7 Rest of Europe Electronic Skin Patch Market
8.7.1 Rest of Europe Electronic Skin Patch Market by End User
8.7.2 Rest of Europe Electronic Skin Patch Market by Type
8.7.3 Rest of Europe Electronic Skin Patch Market by Wireless Connectivity
8.7.4 Rest of Europe Electronic Skin Patch Market by Application
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 DexCom, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Medtronic PLC
9.3.1 Company overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.1 SWOT Analysis
9.4 Insulet Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Boston Scientific Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 SWOT Analysis
9.6 Koninklijke Philips N.V.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.6.6 SWOT Analysis
9.7 The Surgical Company
9.7.1 Company Overview
9.7.2 SWOT Analysis
9.8 VivaLNK, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.8.3 SWOT Analysis
9.9 Blue Spark Technologies, Inc.
9.9.1 Company Overview
9.9.2 SWOT Analysis
9.10. Senseonics Holdings, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis

Companies Mentioned

  • Abbott Laboratories
  • DexCom, Inc.
  • Medtronic PLC
  • Insulet Corporation
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • The Surgical Company
  • VivaLNK, Inc.
  • Blue Spark Technologies, Inc.
  • Senseonics Holdings, Inc.

Methodology

Loading
LOADING...